Elanco Animal Health (ELAN) vs Summit Therapeutics (SMMT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Elanco Animal Health (ELAN) has outperformed Summit Therapeutics (SMMT) over the past year, gaining 14.2% versus a loss of 22.3%. Over five years, SMMT leads with a +241.6% price change compared with -29.6% for ELAN. Summit Therapeutics is the larger company by market cap ($14.03 billion vs $11.45 billion), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAN | SMMT |
|---|---|---|
| Share price | $22.92 | $17.59 |
| Market cap | $11.45B | $14.03B |
| 1-day change | +1.69% | +2.45% |
| YTD return | +1.28% | +0.57% |
| 1-year return | +14.20% | -22.34% |
| 5-year return | -29.56% | +241.55% |
| Forward P/E | 17.84 | — |
| EPS (TTM) | $-0.41 | $-1.14 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.71B | — |
| Revenue growth (YoY) | +6.22% | — |
| Net income (latest FY) | $-232.00M | $-1.08B |
| Gross margin | 54.99% | — |
| Net margin | -4.92% | — |
| 52-week high | $27.98 | $29.23 |
| 52-week low | $19.40 | $12.07 |
| Distance from 52-week high | -18.08% | -39.82% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +35.25% | +69.30% |
| Average volume | 6.22M | 5.87M |
| Shares outstanding | 499.45M | 797.75M |
| Employees | 9,400 | 265 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELAN has outperformed SMMT by 36.5 percentage points over the past year.
- The two companies sit in different sectors: Elanco Animal Health in Health Care and Summit Therapeutics in Healthcare.
About Elanco Animal Health
ELAN stock →Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark.
Health Care · Biotechnology: Pharmaceutical Preparations · 9,400 employees
About Summit Therapeutics
SMMT stock →Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC).
Healthcare · Biotechnology · 265 employees
ELAN vs SMMT FAQ
Which is bigger, Elanco Animal Health or Summit Therapeutics?
Summit Therapeutics (SMMT) is larger, with a market capitalization of $14.03B compared with $11.45B for Elanco Animal Health (ELAN).
Which stock has performed better over the past year, ELAN or SMMT?
ELAN returned +14.20% over the past 12 months, compared with -22.34% for SMMT (price return, excluding dividends). Past performance does not predict future results.
Are Elanco Animal Health and Summit Therapeutics in the same industry?
No. Elanco Animal Health is in the Health Care sector, while Summit Therapeutics is in Healthcare.